Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Conference Coverage

For patients with Behçet disease, ophthalmological involvement is one of the most feared manifestations.
Conference Coverage
Ocular Involvement Among Patients With Behçet’s Disease
11/23/2021
A study presented at the ACR 2021 Convergence found that among patients with Behçet’s disease, the most frequent ocular manifestations were uveitis and retinal vasculitis.
A study presented at the ACR 2021 Convergence found that among patients with Behçet’s disease, the most frequent ocular manifestations were uveitis and retinal vasculitis.
A study presented at the ACR...
11/23/2021
Autoimmune
CT
Conference Coverage
Researchers Find Imaging Technique Can Distinguish PsA from Other Arthritides
11/12/2021
An abstract presented at the American College of Rheumatology 2021 Convergence validated Total-Body 18F-FDG PET/CT imaging for accurately diagnosing psoriatic arthritis.
An abstract presented at the American College of Rheumatology 2021 Convergence validated Total-Body 18F-FDG PET/CT imaging for accurately diagnosing psoriatic arthritis.
An abstract presented at the...
11/12/2021
Rheumatology & Arthritis
xray
Conference Coverage
Impact of Symptomatic Multijoint Osteoarthritis Subtypes on Physical Function
11/06/2021
Specific subtypes of symptomatic multi-joint osteoarthritis, in which at least one joint site is symptomatic, are associated with varying decrements in self-reported physical function.
Specific subtypes of symptomatic multi-joint osteoarthritis, in which at least one joint site is symptomatic, are associated with varying decrements in self-reported physical function.
Specific subtypes of symptomatic...
11/06/2021
Rheumatology & Arthritis

Advertisement

Dr Elizabeth Wallace is a specialist on psoriasis. She presented emerging novel treatments for plaque psoriasis.
Conference Coverage
Emerging Novel Treatments for Plaque Psoriasis
09/17/2021

Jessica Garlewicz, Associate Digital Editor

Jessica Garlewicz, Associate Digital ...
On the second day of Dermatology Week 2021, Dr Elizabeth Wallace introduced new, emerging therapies for the treatment of psoriasis. Read about her session highlights here.
On the second day of Dermatology Week 2021, Dr Elizabeth Wallace introduced new, emerging therapies for the treatment of psoriasis. Read about her session highlights here.
On the second day of Dermatology...
09/17/2021
The Dermatologist
Addressing Clinical Challenges in the Management of SLE With Dr Petri
Conference Coverage
Addressing Clinical Challenges in the Management of SLE With Dr Petri
04/18/2021
The early and accurate diagnosis is essential in the management of systemic lupus erythematosus, according to Michelle Petri, MD, who spoke at the virtual Interdisciplinary Autoimmune Summit on April 17, 2021.
The early and accurate diagnosis is essential in the management of systemic lupus erythematosus, according to Michelle Petri, MD, who spoke at the virtual Interdisciplinary Autoimmune Summit on April 17, 2021.
The early and accurate diagnosis...
04/18/2021
Autoimmune
IMID-JAK Pearls from Dr Ruth Ann Vleugels
Conference Coverage
IMID-JAK Pearls from Dr Ruth Ann Vleugels
04/18/2021
At the Interdisciplinary Autoimmune Summit, Ruth Ann Vleugels, MD, MPH, MBA, presented “Strategies for Improving IMID Outcomes: The Potential of JAK Inhibitors,” sharing a number of pearls when it comes to utilizing JAK inhibitors for the...
At the Interdisciplinary Autoimmune Summit, Ruth Ann Vleugels, MD, MPH, MBA, presented “Strategies for Improving IMID Outcomes: The Potential of JAK Inhibitors,” sharing a number of pearls when it comes to utilizing JAK inhibitors for the...
At the Interdisciplinary...
04/18/2021
Autoimmune

Advertisement

The Future of Cell Therapeutics for Autoimmune Diseases
Conference Coverage
The Future of Cell Therapeutics for Autoimmune Diseases
07/12/2020
At IAS 2020, Biju Parekkadan, PhD, presented the latest evidence for the use of human cell and cellular therapeutics and how it may be used one day to treat patients with autoimmune diseases.
At IAS 2020, Biju Parekkadan, PhD, presented the latest evidence for the use of human cell and cellular therapeutics and how it may be used one day to treat patients with autoimmune diseases.
At IAS 2020, Biju Parekkadan,...
07/12/2020
Autoimmune
Optimizing Treatment Regimens in Immune-Mediated Diseases
Conference Coverage
Optimizing Treatment Regimens in Immune-Mediated Diseases
07/12/2020
Research demonstrates that trough drug concentrations correlate to more positive outcomes in patients with immune-mediated diseases. At IAS 2020, David Hudesman, MD, and Adam Cheifetz, MD, discussed the relative benefits of therapeutic drug...
Research demonstrates that trough drug concentrations correlate to more positive outcomes in patients with immune-mediated diseases. At IAS 2020, David Hudesman, MD, and Adam Cheifetz, MD, discussed the relative benefits of therapeutic drug...
Research demonstrates that...
07/12/2020
Autoimmune
Behçet Disease Presents Complex Diagnostic Challenge
Conference Coverage
Behçet Disease Presents Complex Diagnostic Challenge
07/12/2020
Patients with Behçet disease may wait 9 years for a definitive diagnosis. Delfin Santos, MD, explained why this disease is so difficult to identify in his presentation at the virtual IAS 2020 meeting.
Patients with Behçet disease may wait 9 years for a definitive diagnosis. Delfin Santos, MD, explained why this disease is so difficult to identify in his presentation at the virtual IAS 2020 meeting.
Patients with Behçet disease may...
07/12/2020
Autoimmune

Advertisement

Dr Taft Discusses the Role of CBT for Patients With Autoimmune Diseases
Conference Coverage
Dr Taft Discusses the Role of CBT for Patients With Autoimmune Diseases
07/12/2020
At IAS 2020, Tiffany Taft, PhD, discusses how cognitive behavioral therapy can help patients with autoimmune disease-related mental health symptoms, as well as how and when to refer patients.
At IAS 2020, Tiffany Taft, PhD, discusses how cognitive behavioral therapy can help patients with autoimmune disease-related mental health symptoms, as well as how and when to refer patients.
At IAS 2020, Tiffany Taft, PhD,...
07/12/2020
Autoimmune

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Popular Articles

Conference Insights
Orofacial Granulomatosis
08/06/2018
08/06/2018
Autoimmune
New Anti-Inflammatory Drug Improves Active PsA Symptoms
11/09/2017
Previous trials demonstrated that a drug for moderate to severe plaque psoriasis remained safe and effective through 60 weeks of use. In the UNCOVER-3 study, researchers tested the safety and efficacy of this drug through 108 weeks of use.
Previous trials demonstrated that a drug for moderate to severe plaque psoriasis remained safe and effective through 60 weeks of use. In the UNCOVER-3 study, researchers tested the safety and efficacy of this drug through 108 weeks of use.
Previous trials demonstrated...
11/09/2017
Autoimmune
News
Gut Microbiome Traits Linked With RA Improvement
10/07/2021
Research shows microbiome modification could prove effective in treating autoimmune diseases.
Research shows microbiome modification could prove effective in treating autoimmune diseases.
Research shows microbiome...
10/07/2021
Autoimmune
Quiz
Coexisting RA and AS
04/28/2021
The coexistence of rheumatoid arthritis and ankylosing spondylitis in one patient is rare, often leading to misdiagnosis. Take our quick quiz and find out which patients present key signs at onset.
The coexistence of rheumatoid arthritis and ankylosing spondylitis in one patient is rare, often leading to misdiagnosis. Take our quick quiz and find out which patients present key signs at onset.
The coexistence of rheumatoid...
04/28/2021
Autoimmune
4 Questions About New and Emerging Therapeutic Agents for IBD
Q&As
4 Questions About New and Emerging Therapeutic Agents for IBD
07/11/2020
Stephen B. Hanauer, MD, from Northwestern Medicine, answers our questions about the optimal positioning of new medications for inflammatory bowel disease, which he discussed in his presentation at !AS 2020.
Stephen B. Hanauer, MD, from Northwestern Medicine, answers our questions about the optimal positioning of new medications for inflammatory bowel disease, which he discussed in his presentation at !AS 2020.
Stephen B. Hanauer, MD, from...
07/11/2020
Autoimmune

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Stay In the Know

Autoimmune Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use